Sativa Group PLC New CEO as Geremy Thomas transitions to Deputy Chairman

Sativa Group PLC (NEX:SATI), the UK’s leading quoted CBD Wellness and medicinal cannabis Group, has today announced it has appointed Henry Lees-Buckley as Chief Executive Officer and a Director of the Company with immediate effect. 

Henry was previously CEO of Uni-Select [TSX:UNS], a Canadian TSX quoted company, with operations in the UK, Canada and the USA.  Prior to that he was a senior global executive and officer in the USA and Canada for W.W. Grainger, a US$15 billion Fortune 500 company.  Henry is currently a non-Executive Director of NASDAQ-quoted BMC (Building Materials Corp) [NASDAQ:BMCH] which has sales of US$3.8 billion and a market capitalisation of US$1.6 billion. 

Henry, who holds dual United Kingdom and Canadian citizenship, has held numerous executive level positions both in North America and also the United Kingdom.  He holds an MBA from Queens University, Kingston, Ontario, has moved to the United Kingdom, and from now will operate from Sativa’s Somerset headquarters. 

Sativa’s founder and current Chief Executive Officer Geremy Thomas will transition to the role of Deputy Chairman with immediate effect and will continue to deliver to the Group his significant knowledge and expertise in the medicinal cannabis industry. 

Geremy said: “Henry’s appointment is a clear statement of the Board’s ambition for the Group.  Henry has the enthusiasm, expertise and experience to grow the business significantly.  

“His experience of major capital market businesses, executive leadership and M&A will be of great use as the Company seeks to accelerate both organic and acquisitive growth and attract a broader investor base including institutions.  Appropriate capital markets remain a focus for the Group.” 

 Newly appointed Henry Lees-Buckley said: “Sativa has made remarkable advances in its first 18 months as a quoted vehicle and I am looking forward to working with the team to build on this foundation and guide and grow the business moving forward.  The UK market is particularly exciting as it is adopting already globally proven interest in CBD wellness and medicinal cannabis products.  This provides a significant runway ahead for us and, as Sativa operates in a complex and heavily regulated industry, management strength and controls are key.” 

The past and current directorships of Henry Lees-Buckley are: